Study of Iguratimod in Sjögren's Syndrome
A Preliminary Efficacy Study of Iguratimod in Patients With Sjögren's Syndrome
Sponsor: Peking Union Medical College Hospital
This PHASE1/PHASE2 trial investigates Sjogren's Syndrome and is currently ongoing. Peking Union Medical College Hospital leads this study, which shows 7 recorded versions since 2017 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Unknown PHASE1/PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE1/PHASE2
Status: Unknown Status → Unknown · Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status PHASE1_PHASE2
-
Feb 2019 — Jan 2021 [monthly]
Unknown Status PHASE1_PHASE2
Status: Recruiting → Unknown Status
-
Aug 2018 — Feb 2019 [monthly]
Recruiting PHASE1_PHASE2
▶ Show 2 earlier versions
-
Jul 2018 — Aug 2018 [monthly]
Recruiting PHASE1_PHASE2
-
Feb 2017 — Jul 2018 [monthly]
Recruiting PHASE1_PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Peking Union Medical College Hospital
For direct contact, visit the study record on ClinicalTrials.gov .